STOCK TITAN

DIH Holding US, Inc. (NASDAQ: DHAI) details Nasdaq listing and filing deficiencies

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

DIH Holding US, Inc. reports that Nasdaq is now considering multiple listing deficiencies that could lead to delisting of its Class A common stock and warrants. The company failed to regain compliance with Nasdaq’s market value of publicly held shares rule, which requires at least $15,000,000, within the 180‑day grace period ending October 1, 2025. This comes on top of earlier notices tied to its market value of listed securities falling below $50,000,000 and its share price staying under $1.00 for 30 consecutive business days.

On October 7, 2025, Nasdaq’s Hearings Panel informed the company it will factor this new deficiency into its decision on continued listing. DIH has requested a hearing and a stay of suspension while it presents a plan to regain compliance with all rules, including overdue Form 10‑Q and Form 10‑K reports. The Panel may grant time extensions, but there is no assurance DIH will maintain its Nasdaq Global Market listing.

Positive

  • None.

Negative

  • Nasdaq delisting risk: Multiple, unresolved deficiencies (market value of publicly held shares, market value of listed securities, bid price, and SEC reporting delays) are now formal bases for potential delisting from the Nasdaq Global Market.
  • Regulatory reporting delinquency: The company has not filed its Form 10‑Q for the period ended June 30, 2025 or Form 10‑K for the period ended March 31, 2025, adding to listing pressure.

Insights

Multiple Nasdaq deficiencies create real delisting risk for DIH.

DIH Holding US, Inc. now faces several concurrent Nasdaq listing issues: market value of publicly held shares below $15,000,000, market value of listed securities below $50,000,000, and a bid price under $1.00 for 30 consecutive business days. Each missed its 180‑day cure window, so these now serve as formal bases for delisting.

The company has also fallen behind on SEC reporting, having not filed its Form 10‑Q for the period ended June 30, 2025 and Form 10‑K for the period ended March 31, 2025. That reporting delinquency is an additional listing concern and prompted DIH to request an extended stay while it appears before Nasdaq’s Hearings Panel.

The Panel can grant up to 180 days from the delisting determination for the market‑based rules and up to 360 days from the initial filing delinquency. Whether DIH remains on the Nasdaq Global Market depends on the strength of its compliance plan and its ability to meet these requirements within any extension period the Panel may allow.

false 0001883788 0001883788 2025-10-07 2025-10-07 0001883788 DHAI:ClassCommonStockMember 2025-10-07 2025-10-07 0001883788 DHAI:WarrantsMember 2025-10-07 2025-10-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 7, 2025

 

DIH HOLDING US, INC.

(Exact name of Registrant as Specified in Its Charter)

 

Delaware   001-41250   98-1624542

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

77 Accord Park Drive;

Suite D-1

Norwell, Massachusetts

  02061
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 877 944-2200

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A Common Stock   DHAI   The Nasdaq Stock Market LLC
Warrants   DHAIW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

As previously disclosed, on April 4, 2025, the Listing Qualifications Staff (“Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notified DIH Holding US, Inc. (the “Company”) that for the previous 30 consecutive trading days the market value of its publicly held shares had been below the minimum $15,000,000 required for continued listing as set forth in Listing Rule 5450(b)(2)(C) (the “MVPHS Rule”). Therefore, in accordance with Marketplace Rule 5810(c)(3)(D), the Company was provided 180 calendar days, or until October 1, 2025, to regain compliance with the Rule. The Company has not regained compliance with the Rule. Accordingly, this matter serves as an additional basis for delisting the Company’s securities from The Nasdaq Stock Market.

 

On October 7, 2025, (the “October Letter”) the Company received formal notification from the Staff that the Nasdaq Hearings Panel (the “Panel”) will consider this matter in rendering a determination regarding the Company’s continued listing on The Nasdaq Global Market. The October Letter provided that pursuant to Listing Rule 5810(d), the Company should present its views with respect to this additional deficiency at its Panel hearing. If the Company fails to address the aforementioned issue, the Panel will consider the record as presented at the hearing and will make its determination based upon that information.

 

As previously disclosed, on March 5, 2025, the Company received written notice from Staff which notified the Company that, for the previous 30 consecutive business days prior to the date of the MVLS Notice, the Company’s market value of listed securities (“MVLS”) closed below the $50,000,000 MVLS threshold required for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company was provided with a compliance period of 180 calendar days in which to regain compliance with the MVLS continued listing requirement, or until September 1, 2025. The Company did not regain compliance with the MVLS Rule by September 1, 2025, and, accordingly, by letter dated September 2, 2025, the Staff notified the Company that its securities were subject to delisting from Nasdaq unless the Company timely requests a hearing before the Panel.

 

As previously disclosed, on March 11, 2025, the Company received written notice from Staff which notified the Company that the bid price of its Class A common stock had closed at less than $1.00 per share for the previous 30 consecutive business days prior to the date of the Bid Price Notice, as required for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) (the “Bid Price Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company was provided with a compliance period of 180 calendar days in which to regain compliance with the Bid Price Rule, or until September 8, 2025. The Company did not regain compliance with the Bid Price Rule by September 8, 2025, and, accordingly, by letter dated September 12, 2025, the Staff notified the Company that this matter would serve as an additional basis for delisting, so it would need to address it before the Panel.

 

The Company has requested a hearing before the Panel, which has stayed the suspension of the Company’s Common Stock for a period of 15 days. In connection with this request, the Company also requested an extended stay of any further action pending the hearing (the “Additional Stay”) due to its non-compliance with the (the “Reports Rule”) as referenced in an additional basis for delisted dated September 12, 2025, since it has not filed its Form 10-Q for the period ended June 30, 2025 and Form 10-K for the period ended March 31, 2025. At the hearing, the Company will present its plan to evidence compliance with all applicable listing criteria, including the MVPHS Rule, the MVLS Rule, the Bid Price Rule and the Reports Rule, and request an extension of time. The Panel has the authority to grant the Company an extension of up to 180 days from the date of the Staff’s delist determination for the MVPHS, MVLS, and Bid Price Rules and 360 days from the initial filing delinquency. The Company is considering all options available to it to regain compliance with the MVPHS Rule, MVLS Rule, the Bid Price Rule and the Reports Rule; however, there can be no assurance that the Panel will grant the Company’s request for continued listing or that the Company will be able to evidence compliance within the period of time that may be granted by the Panel.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  DIH HOLDING US, INC.
     
Date: October 8, 2025 By: /s/ Jason Chen
   

Jason Chen

Chief Executive Officer and Chairman

 

 

 

FAQ

What Nasdaq rules is DIH (DHAI) currently not in compliance with?

DIH Holding US, Inc. is out of compliance with the Nasdaq market value of publicly held shares rule requiring at least $15,000,000, the market value of listed securities rule requiring $50,000,000, the $1.00 minimum bid price rule, and a reporting rule tied to delayed Form 10‑Q and Form 10‑K filings.

What happens next with DIH Holding US, Inc.’s Nasdaq listing?

Nasdaq’s Hearings Panel will review DIH’s multiple deficiencies and the company’s plan to regain compliance. The Panel can grant extensions of up to 180 days for the market‑based rules and up to 360 days from the initial filing delinquency, but there is no assurance continued listing will be granted.

Why is DIH at risk of delisting for market value of publicly held shares?

Nasdaq notified DIH that its market value of publicly held shares had been below the required $15,000,000 for 30 consecutive trading days, and the company did not regain compliance by the October 1, 2025 deadline, making this an additional basis for delisting.

How did DIH fail the Nasdaq market value of listed securities and bid price tests?

DIH’s market value of listed securities closed below $50,000,000 for 30 consecutive business days before March 5, 2025, and its Class A common stock’s bid price stayed below $1.00 for 30 consecutive business days before March 11, 2025, and it did not cure either deficiency within the 180‑day compliance periods.

Which SEC reports has DIH not filed on time?

DIH has not filed its Form 10‑Q for the period ended June 30, 2025 and its Form 10‑K for the period ended March 31, 2025, and this reporting delinquency is referenced as an additional basis for potential delisting.

Has DIH requested any stay of suspension from Nasdaq?

Yes. DIH requested a hearing before the Nasdaq Hearings Panel, which stayed suspension of its common stock for 15 days, and it also requested an additional stay of further action pending the hearing due to its reporting and listing deficiencies.
DIH Holdings US

NASDAQ:DHAI

DHAI Rankings

DHAI Latest News

DHAI Latest SEC Filings

DHAI Stock Data

1.56M
1.51M
45.62%
7.31%
2.11%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
NORWELL